sotalol has been researched along with Hyperpotassemia in 4 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isoproterenol and propranolol, in a single dose, caused hyperglycemia after 15 and 30 min, either in the conscious rat or in the anesthetized dog." | 3.65 | Metabolic responses to catecholamines. ( Aramendía, P; Márquez, MT; Puntoni de Mikulic, LE, 1976) |
| "Presumptive treatment for hyperkalemia was started based on her initial electrocardiogram." | 1.39 | Life-threatening hyperkalemia: a potentially lethal drug combination. ( Gourineni, VC; Juvet, T; Ravi, S; Zarich, SW, 2013) |
| "Hyperkalemia is a potentially life-threatening disorder frequently occurring in hospitalized patients." | 1.34 | The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. ( Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juvet, T | 1 |
| Gourineni, VC | 1 |
| Ravi, S | 1 |
| Zarich, SW | 1 |
| Lin, C | 1 |
| Ke, X | 1 |
| Cvetanovic, I | 1 |
| Ranade, V | 1 |
| Somberg, J | 1 |
| Puntoni de Mikulic, LE | 1 |
| Márquez, MT | 1 |
| Aramendía, P | 1 |
| Lockwood, RH | 1 |
| Lum, BK | 1 |
4 other studies available for sotalol and Hyperpotassemia
| Article | Year |
|---|---|
Life-threatening hyperkalemia: a potentially lethal drug combination.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Diuretics; Drug-Related Side Effects and Adverse Reaction | 2013 |
The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Disease Models, Animal; Electro | 2007 |
Metabolic responses to catecholamines.
Topics: Animals; Catecholamines; Dogs; Drug Interactions; Epinephrine; Hyperglycemia; Hyperkalemia; Hypokale | 1976 |
Effects of adrenergic agonists and antagonists on potassium metabolism.
Topics: Albuterol; Animals; Blood Glucose; Blood Pressure; Butoxamine; Cats; Epinephrine; Ethanolamines; Hea | 1974 |